
182781842 | KPMMCO | 49695934 | | 0238686 | 10/12/2005 12:00:00 AM | CHF , pneumonia | | DIS | Admission Date: 10/11/2005 Report Status:
Discharge Date: 4/30/2005
****** FINAL DISCHARGE ORDERS ******
SAMU , CURTIS 550-19-26-3
Beth Ba Ri
Service: MED
DISCHARGE PATIENT ON: 1/13/05 AT 04:00 PM
CONTINGENT UPON Attending evaluation
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: TIMBERLAKE , MEL WYATT , M.D.
CODE STATUS:
Full code
DISPOSITION: Assisted Living
DISCHARGE MEDICATIONS:
ACETYLSALICYLIC ACID 81 MG PO QD
Override Notice: Override added on 10/21/05 by
THEUNISSEN , LYNWOOD D.
on order for COUMADIN PO ( ref # 30990956 )
POTENTIALLY SERIOUS INTERACTION: ASPIRIN & WARFARIN
Reason for override: aware Previous override information:
Override added on 1/1/05 by BOURNS , WALTON JERALD , M.D.
on order for COUMADIN PO ( ref # 86899543 )
POTENTIALLY SERIOUS INTERACTION: ASPIRIN & WARFARIN
Reason for override: aware
DIGOXIN 0.125 MG PO QD
Override Notice: Override added on 1/1/05 by CHRISTOFFERSE , KRIS MARCELLUS , M.D.
on order for LEVOTHYROXINE SODIUM PO ( ref # 05958677 )
POTENTIALLY SERIOUS INTERACTION: DIGOXIN & LEVOTHYROXINE
SODIUM Reason for override: aware
COLACE ( DOCUSATE SODIUM ) 100 MG PO BID
FERROUS SULFATE 325 MG PO BID
Food/Drug Interaction Instruction Avoid milk and antacid
MOTRIN ( IBUPROFEN ) 600 MG PO Q8H Starting Today ( 2/14 )
PRN Pain Food/Drug Interaction Instruction Take with food
LEVOTHYROXINE SODIUM 75 MCG PO QD
Override Notice: Override added on 10/21/05 by
CONNELLY , ELIAS E.
on order for COUMADIN PO ( ref # 30990956 )
SERIOUS INTERACTION: LEVOTHYROXINE SODIUM & WARFARIN
Reason for override: aware Previous override information:
Override added on 1/1/05 by ORMONDE , GUY NICHOLAS , M.D.
POTENTIALLY SERIOUS INTERACTION: DIGOXIN & LEVOTHYROXINE
SODIUM SERIOUS INTERACTION: WARFARIN & LEVOTHYROXINE SODIUM
Reason for override: aware
REGLAN ( METOCLOPRAMIDE HCL ) 5 MG PO AC
SIMETHICONE 80 MG PO QID
VITAMIN B1 ( THIAMINE HCL ) 100 MG PO QD
TRAZODONE 50 MG PO HS
COUMADIN ( WARFARIN SODIUM ) 5 MG PO QPM
Starting ROUTINE , 20:00 ( Standard Admin Time )
Food/Drug Interaction Instruction
No high Vitamin-K containing foods
Alert overridden: Override added on 10/21/05 by
MORKVE , OLLIE J.
POTENTIALLY SERIOUS INTERACTION: ASPIRIN & WARFARIN
SERIOUS INTERACTION: LEVOTHYROXINE SODIUM & WARFARIN
POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN & WARFARIN
POTENTIALLY SERIOUS INTERACTION: LEVOFLOXACIN & WARFARIN
POTENTIALLY SERIOUS INTERACTION: LEVOFLOXACIN & WARFARIN
Reason for override: aware
MVI THERAPEUTIC ( THERAPEUTIC MULTIVITAMINS ) 1 TAB PO QD
Alert overridden: Override added on 1/1/05 by
MUNGO , KOREY DEON , M.D.
POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN & NIACIN ,
VIT. B-3 Reason for override: aware
TOPROL XL ( METOPROLOL SUCCINATE EXTENDED RELEASE )
75 MG PO QD Food/Drug Interaction Instruction
Take consistently with meals or on empty stomach.
Number of Doses Required ( approximate ): 10
GABAPENTIN 200 MG PO QD
TORSEMIDE 100 MG PO BID
COZAAR ( LOSARTAN ) 50 MG PO QD
Number of Doses Required ( approximate ): 10
LEVOCARNITINE 1 GM PO QD Starting Today ( 4/24 )
Instructions: on 15 ml at home
Number of Doses Required ( approximate ): 10
CITALOPRAM 20 MG PO QD
ADVAIR DISKUS 250/50 ( FLUTICASONE PROPIONATE/... )
1 PUFF INH BID
Override Notice: Override added on 1/1/05 by WHITESELL , OTIS DARRICK , M.D.
on order for LEVOFLOXACIN PO ( ref # 2 of February )
POTENTIALLY SERIOUS INTERACTION: SALMETEROL XINAFOATE &
LEVOFLOXACIN Reason for override: aware
NEXIUM ( ESOMEPRAZOLE ) 20 MG PO QD
LANTUS ( INSULIN GLARGINE ) 60 UNITS SC QHS
NOVOLOG ( INSULIN ASPART )
Sliding Scale ( subcutaneously ) SC AC
If BS is less than 125 , then give 0 units subcutaneously
If BS is 125-150 , then give 2 units subcutaneously
If BS is 151-200 , then give 3 units subcutaneously
If BS is 201-250 , then give 4 units subcutaneously
If BS is 251-300 , then give 6 units subcutaneously
If BS is 301-350 , then give 8 units subcutaneously
If BS is 351-400 , then give 10 units subcutaneously and
call HO Call HO if BS is greater than 400
LIPITOR ( ATORVASTATIN ) 10 MG PO QPM
Alert overridden: Override added on 10/21/05 by :
POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &
ATORVASTATIN CALCIUM
POTENTIALLY SERIOUS INTERACTION: WARFARIN & ATORVASTATIN
CALCIUM Reason for override: aware
COMBIVENT ( IPRATROPIUM AND ALBUTEROL SULFATE )
2 PUFF INH QID
DIET: House / Low chol/low sat. fat
DIET: House / ADA 1800 cals/dy
DIET: 2 gram Sodium
ACTIVITY: Resume regular exercise
FOLLOW UP APPOINTMENT( S ):
Follow up with you Primary Care Provider within the next two weeks ,
Arrange INR to be drawn on 6/25/05 with f/u INR's to be drawn every
2 days. INR's will be followed by Dr. Hechinger AH
ALLERGY: SHRIMP
ADMIT DIAGNOSIS:
CHF , pneumonia
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
CHF , pneumonia
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
Adriamycin induced CMP HTN IDDM Sarcoid
Left Breast CA- s/p lumpect and XRT/Adria-'84 hypercholesterolemia
? GI origin of epigastric pain dvt ( deep venous thrombosis )
osteoarthritis ( unspecified or generalized OA ) hypothyroid
( hypothyroidism ) cad ( )
OPERATIONS AND PROCEDURES:
none
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
Midline placed on 4/30 for blood draws but did not work. Midline taken
out before discharge.
BRIEF RESUME OF HOSPITAL COURSE:
CC: SOB
HPI: 61 yo F with multiple medical problems , including dilated CMP ,
s/p chemo and XRT for Breast CA , CAD , s/p MI , COPD , on occasional O2 ,
presents with dry cough associated with some SOB x 2 days
and increased DOE as well. At baseline pt is able to walk 1 block
( with walker ) before DOE , now DOE after 1/2 block. Pt denies CP. Pt
reports orthopnea and PND. Pt has chronic abd pain at baseline that
has been evaluated in the past with Abd CT , U/S showing sludge. Pt
has a Hx of increased Alk Phos. She reports no change in abd pain at
this time , except increased bloating. No increased leg edema ,
but reports increased in size of L arm. Pt also reports wheezing
without increased O2 need at night. No sick contacts , no diarrhea , no
constipation.
****
PE on admission: VS: T97.8 HR73 BP113/71 RR18 O2Sat 92%
Gen: NAD
HEENT: oropharynx clear , no JVD
CV: distant heart sounds , 1/6 SEM
Pulm:ant. endexp wheezes , no crackles
Abd: mild tenderness in epigastrium , RUQ , distended
Ext:Venous stasis , 1+ edema , L arm larger than R arm
*****
Tests: ALK Phos: 627
ALT: 71
AST: 65
Card Enzymes: neg
WBC: 6.4
UA: 1.011 , 1+prot , 5-10WBC , 2+bact
CXR: LLL opacity , seen best on lateral view
EKG: prolonged PR , q in AVL , flat Ts laterally , unchanged from 5/26
RUQ US: sludge , gall bladder wall thickened 8mm , neg sonographic
Murphy's sign , B/L small pleural effusions
1/9 Echo: EF 25% , LV mild to mod dilated at 4.2cm , some RWMA ,
mod-severe MR
4/20 Abd U/S: sludge in gallbladder
1/9 Abd CT: Ascites
1/9 PE protocol CT: mild edema , bilat. effusions , anasarca
**********************************************************************
HOSPITAL COURSE:
61F with LLL PNA and CHF
1. ) ID: Pt placed on po levofloxacin for LLL pneumonia. She received a 7
days course and symptoms resolved. Stable vitals and O2 sats.
2. ) Pulm: HX of CHF. Pt's weight 227lbs 2/30/05 ( dry weight ~ 200 ). Pt
on torsemide 100mg bid at baseline. Pt given po lasix ( in place of
torsemide on admit ) and was increased to 200bid x 2 doses. Then , pt
placed back on torsemide and zaroxyln 5mg po BID x 6 doses was added.
Lytes closely monitored , however , pt was difficult to draw
blood from secondary to poor access. Followed daily weights. On D/C , pt's
breathing was improved and she was ambulating with walker @ her baseline..
Lungs were clear and pt still had BLE edema on d/c.
3. ) GI: Hx of gallbladder sludge , with chronic RUQ pain , w/u with CT and
US in the past , but pt not surgical candidate. RUQ US showed just sludge ,
gallbladder wall thickened 8mm , neg sonographic murphy's sign.
4. ) Rheum- 2/3 pt c/o right thumb pain- thumb was
red , warm , and painful to touch at joint. Pt has h/o gout-
was started on motrin TID.
6. ) Endo- BS were high during hospitalization and insulin was adjusted
appropriately. Lantus increased to 60mg QHS and novolog 8u QAC and
sliding scale. Pt will be d/c'd home on lantus 60u QHS with novolog
sliding scale.
7. ) Heme- Pt was restarted on coumadin 5mg po QD for DVT on
10/3 Follow up INR to be drawn on 2/17 INR on 2/3 was 1.2.
FULL CODE.
ADDITIONAL COMMENTS: 1. ) Primary care follow up to check lytes on torsemide.
2. ) INR checks to be arranged by RMC and coumadin dosing to be called
into Ak Heim pharmacy.
3. ) Monitor weight 2x/week
4. ) VNA arranged
DISCHARGE CONDITION: Stable
TO DO/PLAN:
1. INR to be checked on 8/7 ( goal 2-3 ). Pt sent home on coumadin 5mg po
QHS. INR results interepreted by NH and coumadin dose should be calle
into A Larepitbrown Lyoco pharmacy 807-526-4223.
2. Continue diuresis with torsemide 100mg twice a day and monitor
weights 2x/week. Keep legs elevated while in bed to help reduce swelling.
3. Please make follow up appointment with Dr. Danahy within the
next two weeks. You will need follow up blood work.
4. Take motrin 600mg as needed for your thumb pain. Once pain resolves ,
resume taking your allopurinol 100mg daily for gout prophylaxis.
5. Your lantus insulin dose was increased to 60units at night. Please
continue your sliding scale as usual.
6. You no longer need procrit , as your blood levels were within normal
range. Follow up with your PCP for bloodwork monitoring.
7. Contact your primary care provider or come to the emergency room if
you experience difficulty breathing , chest pain , or fever.
No dictated summary
ENTERED BY: FLY , RENATO T. ( MN92 ) 1/13/05 @ 01:29 PM
****** END OF DISCHARGE ORDERS ******